Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retinoblastoma: An overview.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society·2014
Same author

A Retrospective Clinical Study of the Etiology and Post-operative Visual Outcome of Rhegmatogenous Retinal Detachment.

Journal of clinical and diagnostic research : JCDR·2014
See all related articles

Related Experiment Video

Updated: May 2, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.7K

Study of long term structural and functional changes in medically controlled glaucoma.

Achyut N Pandey1, S Sujata2

  • 1Department of Ophthalmology, VCSG Medical College and Research Institute, Srinagar Garhwal, Uttarakhand 246174, India.

International Journal of Ophthalmology
|March 18, 2014
PubMed
Summary
This summary is machine-generated.

Non-beta-blockers effectively lower intraocular pressure and prevent vision loss in primary open-angle glaucoma (POAG) patients, similar to beta-blockers. They offer a favorable side effect profile, making them a strong first-line treatment option for glaucoma.

Keywords:
mean deviationoptical coherence tomographypattern standard deviationretinal nerve fibre layer

More Related Videos

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

9.3K
A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice
07:00

A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice

Published on: October 5, 2018

10.2K

Related Experiment Videos

Last Updated: May 2, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.7K
Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

9.3K
A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice
07:00

A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice

Published on: October 5, 2018

10.2K

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Glaucoma Research

Background:

  • Primary open-angle glaucoma (POAG) is a progressive optic neuropathy leading to visual field loss.
  • Medical therapy aims to reduce intraocular pressure (IOP) to prevent further optic nerve damage.
  • Beta-blockers and non-beta-blockers are common first-line treatments for POAG.

Purpose of the Study:

  • To prospectively analyze long-term structural and functional changes in POAG patients receiving medical therapy.
  • To evaluate if medical IOP reduction prevents or delays visual field loss and optic nerve damage.
  • To compare the efficacy and safety of beta-blockers versus non-beta-blockers in POAG management.

Main Methods:

  • A 27-month prospective study involving 40 POAG patients (80 eyes).
  • Patients were divided into two groups: beta-blockers and non-beta-blockers.
  • Evaluations included IOP, visual acuity, fundus examination, visual field testing, and retinal nerve fiber layer (RNFL) thickness via OCT.

Main Results:

  • Both beta-blocker and non-beta-blocker groups showed statistically significant IOP reduction.
  • No significant differences were observed in visual field parameters (MD, PSD) between the groups.
  • A statistically significant difference was found in mean inferior RNFL thickness between the beta-blocker and non-beta-blocker groups.

Conclusions:

  • Non-beta-blockers are as effective as beta-blockers in lowering IOP and preserving visual fields and RNFL.
  • Non-beta-blockers demonstrate a favorable side effect profile compared to beta-blockers.
  • Non-beta-blockers are a compelling first-line therapy for POAG due to efficacy and tolerability.